Arkolith/Insider Trading/CINC/Form 4

Sofinnova Capital IX

10% OwnerCinCor Pharma, Inc. (CINC) · full profile →Form 4 · filed Jan 13, 2022
Net Buying
Open-Market Buys
$3.5M
Open-Market Sells
$0
Net Open-Market Flow
$3.5M
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 11, 2022Conversion(C)3.9M——3.9M
Jan 11, 2022Buy(P)220K$16.00$3.5M4.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 11, 2022Conversion(C)3.1M—$00
Jan 11, 2022Conversion(C)10.0M—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-003195) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML